Nothing Special   »   [go: up one dir, main page]

CA2429254A1 - Distribution orale de nanospheres - Google Patents

Distribution orale de nanospheres Download PDF

Info

Publication number
CA2429254A1
CA2429254A1 CA002429254A CA2429254A CA2429254A1 CA 2429254 A1 CA2429254 A1 CA 2429254A1 CA 002429254 A CA002429254 A CA 002429254A CA 2429254 A CA2429254 A CA 2429254A CA 2429254 A1 CA2429254 A1 CA 2429254A1
Authority
CA
Canada
Prior art keywords
formulation
heparin
agent
nanospheres
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002429254A
Other languages
English (en)
Inventor
James M. Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
PR Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PR Pharmaceuticals Inc filed Critical PR Pharmaceuticals Inc
Publication of CA2429254A1 publication Critical patent/CA2429254A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des préparations pharmaceutiques orales nanoparticulaires et des méthodes afférentes destinées à la libération régulée d'agents macromoléculaires et/ou chimiothérapeutiques.
CA002429254A 2000-11-20 2001-11-20 Distribution orale de nanospheres Abandoned CA2429254A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25207000P 2000-11-20 2000-11-20
US60/252,070 2000-11-20
PCT/US2001/043299 WO2002041829A2 (fr) 2000-11-20 2001-11-20 Distribution orale de nanospheres

Publications (1)

Publication Number Publication Date
CA2429254A1 true CA2429254A1 (fr) 2002-05-30

Family

ID=22954465

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002429254A Abandoned CA2429254A1 (fr) 2000-11-20 2001-11-20 Distribution orale de nanospheres

Country Status (3)

Country Link
AU (1) AU2002239279A1 (fr)
CA (1) CA2429254A1 (fr)
WO (1) WO2002041829A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036169A2 (fr) 2000-10-31 2002-05-10 Pr Pharmaceuticals, Inc. Methodes et compositions pour ameliorer l'administration de molecules bioactives
WO2004091494A2 (fr) 2003-04-11 2004-10-28 Pr Pharmaceuticals Inc. Procede de preparation de conjugues de proteines specifiques de site
EP1774971A1 (fr) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Nanoparticules comprenant de chitosane et d'héparine
US20070212393A1 (en) * 2006-03-08 2007-09-13 Sahajanand Medical Technologies Pvt. Ltd. Compositions and coatings for implantable medical devices
ES2310122B1 (es) 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
US7998502B2 (en) * 2008-03-24 2011-08-16 Advanced Bionutrition Corp. Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
EP2153821A1 (fr) * 2008-08-06 2010-02-17 BioAlliance Pharma Formules orales de dérivés de camptothécine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent

Also Published As

Publication number Publication date
WO2002041829A3 (fr) 2002-07-18
AU2002239279A1 (en) 2002-06-03
WO2002041829A2 (fr) 2002-05-30

Similar Documents

Publication Publication Date Title
Kreuter Nanoparticle-based dmg delivery systems
Stevanovic et al. Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins
JP5737843B2 (ja) 生理活性分子の向上した送達のための方法及び組成物
Bala et al. PLGA nanoparticles in drug delivery: the state of the art
KR101243689B1 (ko) 미립자 및 의약품 조성물
EP2308473A1 (fr) Composition pharmaceutique contenant des microparticules à revêtement de surface
WO1997004747A1 (fr) Systemes d'administration de medicaments pour medicaments macromoleculaires
US20100316722A1 (en) Pharmaceutical Forms for the Release of Active Compounds
JP2006514698A (ja) ナノ粒子生物活性物質
AU2002220002A1 (en) Methods and compositions for enhanced delivery of bioactive molecules
JP2014533740A (ja) 疎水性薬物送達材料、その製造方法および薬物送達組成物の送達方法
JP2013525351A (ja) ナノ粒子の医薬組成物
JP4073478B2 (ja) 生物分解性制御放出型微細球およびその製法
WO2007114552A1 (fr) Nanoparticules à structures de noyau lipidique et d'enrobage polymère pour administrer des médicaments à base de protéines préparés par nano-encapsulation
CA2429254A1 (fr) Distribution orale de nanospheres
WO2007036946A1 (fr) Préparations permettant l'amélioration de l'absorption d'agents biologiquement actifs
ROGHANIAN et al. Preparation of protein-loaded PLGA-PVP blend nanoparticles by nanoprecipitation method: Entrapment, Initial burst and drug release kinetic studies
Thanos et al. Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer
Momoh et al. Design, characterization and evaluation of PEGylated-mucin for oral delivery of metformin hydrochloride
Paul et al. Fatty acid conjugated calcium phosphate nanoparticles for protein delivery
JP2837675B2 (ja) 徐放性微粒製剤
EP2219611B1 (fr) Formes pharmaceutiques permettant la libération de composés actifs
JP2002527376A (ja) 活性物質非経口投与用組成物
Myers et al. Optimization and modeling of PEGylated, hydrocortisone‐17‐butryate‐loaded poly (lactic‐co‐glycolic acid) microspheres
KR101130756B1 (ko) 로시글리타존을 포함하는 경구투여용 나노입자 전달체 및이의 제조방법

Legal Events

Date Code Title Description
FZDE Discontinued